Rochester Medical Corporation - Current report filing (8-K)
August 15 2008 - 4:36PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
Date of Report (Date of Earliest Event Reported):
|
|
August 15, 2008
|
Rochester Medical Corporation
__________________________________________
(Exact name of registrant as specified in its charter)
|
|
|
Minnesota
|
0-18933
|
41-1613227
|
_____________________
(State or other jurisdiction
|
_____________
(Commission
|
______________
(I.R.S. Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
|
|
One Rochester Medical Drive, Stewartville, Minnesota
|
|
55976
|
_________________________________
(Address of principal executive offices)
|
|
___________
(Zip Code)
|
|
|
|
Registrants telephone number, including area code:
|
|
507-533-9600
|
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) Effective August 15, 2008, Peter R. Conway has resigned from the Board of Directors of Rochester Medical Corporation (the "Company") to focus more fully on other business ventures. Mr. Conway served as a Director of the Company since May 1988. The Company’s Nominating Committee will undertake a review of potential director candidates to fill the vacancy on the Board left by Mr. Conway’s departure.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Rochester Medical Corporation
|
|
|
|
|
|
August 15, 2008
|
|
By:
|
|
/s/ David A. Jonas
|
|
|
|
|
|
|
|
|
|
Name: David A. Jonas
|
|
|
|
|
Title: Chief Financial Officer
|
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From May 2024 to Jun 2024
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Jun 2023 to Jun 2024